Gkv Capital Management Co., Inc. Ionis Pharmaceuticals Inc Transaction History
Gkv Capital Management Co., Inc.
- $120 Billion
- Q1 2025
A detailed history of Gkv Capital Management Co., Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 80 shares of IONS stock, worth $2,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80Holding current value
$2,638% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$540 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$533 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$408 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$340 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$278 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.68B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...